Global Biopharmaceutical Third Party Logistics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Supply;

Cold Chain Logistics, and Non-cold chain logistics.

By Service;

Transportation(Airfreight, Sea freight, and Overland transportation), Warehousing & Storage, and Others.

By Function;

Domestic Transportation Management, International Transportation Management, and Value-added Warehousing and Distribution.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn154480325 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Biopharmaceutical Third Party Logistics Market (USD Million), 2021 - 2031

In the year 2024, the Global Biopharmaceutical Third Party Logistics Market was valued at USD 11,676.45 million. The size of this market is expected to increase to USD 17,098.51 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.6%.

Biopharmaceuticals, including vaccines, biologics, and other complex drugs, require stringent handling and transportation conditions to maintain their efficacy and safety. This has led to a heightened demand for 3PL providers with expertise in temperature-controlled logistics, regulatory compliance, and real-time tracking solutions. These specialized logistics services ensure that biopharmaceutical products are stored, handled, and delivered under optimal conditions, meeting the stringent standards set by regulatory bodies such as the FDA and EMA.

The rise in global pharmaceutical trade, advancements in biologics, and the expansion of biopharmaceutical manufacturing capabilities in emerging markets have further fueled the growth of the biopharmaceutical 3PL market. Companies are increasingly outsourcing their logistics operations to third-party providers to focus on core competencies and reduce operational costs. This outsourcing trend is supported by the scalability, flexibility, and technological innovations offered by 3PL providers, such as automated warehouses, blockchain for supply chain transparency, and IoT-enabled temperature monitoring. As a result, the biopharmaceutical 3PL market is poised for continued expansion, driven by the ongoing evolution of the global pharmaceutical landscape and the critical need for reliable, specialized logistics services.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Supply
    2. Market Snapshot, By Service
    3. Market Snapshot, By Function
    4. Market Snapshot, By Region
  4. Global Biopharmaceutical Third Party Logistics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing biopharmaceutical industry
        2. Increasing demand for temperature-controlled logistics
        3. Advancements in logistics technology
        4. Growth in biologics and personalized medicine
      2. Restraints
        1. Risks of temperature excursions
        2. Security concerns for high-value shipments
        3. Dependence on third-party logistics providers
      3. Opportunities
        1. Adoption of advanced technologies
        2. Expansion into emerging markets
        3. Development of green logistics solutions
        4. Growth in direct-to-patient logistics
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Biopharmaceutical Third Party Logistics Market, By Supply, 2021 - 2031 (USD Million)
      1. Cold Chain Logistics
      2. Non-cold Chain Logistics
    2. Global Biopharmaceutical Third Party Logistics Market, By Service, 2021 - 2031 (USD Million)
      1. Transportation
        1. Airfreight
        2. Sea freight
        3. Overland transportation
      2. Warehousing & Storage
      3. Others
    3. Global Biopharmaceutical Third Party Logistics Market, By Function, 2021 - 2031 (USD Million)
      1. Domestic Transportation Management
      2. International Transportation Management
      3. Value-added Warehousing
      4. Distribution
    4. Global Biopharmaceutical Third Party Logistics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. FedEx.
      2. DHL International GmbH
      3. SF Express
      4. United Parcel Service of America, Inc.
      5. AmerisourceBergen Corporation
      6. DB Schenker
      7. Kerry Logistics Network Limited
      8. Agility
      9. LeK Pharmaceuticals
      10. Hitachi Transport System, Ltd.
      11. XPO Logistics
  7. Analyst Views
  8. Future Outlook of the Market